Affimed (AFMD) Announces Angus Smith as CFO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Affimed Announces Appointment of Angus Smith as Chief Financial Officer
June 11, 2020 6:30 AM EDT
 Mr. Smith brings broad financial management and US capital markets expertise
Heidelberg, Germany, June 11, 2020 Â Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced the appointment of Angus Smith as Chief Financial Officer, completing Affimeds leadership team. Mr. Smith will begin his employment on July 13, 2020 and will be based out of Affimeds New York office.
Mr. Smith has broad biopharmaceutical industry experience including financial strategy, capital markets,... More
